***A previous version of this article indicated that Numinus had a contract with MAPS to produce MDMA for the phase III trial—they do not. I regret the error and apologize for the mistake and thank you for the comment pointing this out*****

It was an error based on this section from the pitch deck:

Again, I regret the error and apologize to the involved p…